Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
May 20, 2026American Journal of Respiratory and Critical Care Medicine

B42-17 Does Lung Involvement Predict Adverse Cardiac Outcomes in Cardiac Sarcoidosis?

View Full Paper
Ask AI
Bookmark
Share

Authors

ALA C LemmaYLY LiuAMA Mahdi

Discussion

Loading...

Member takes

Overview

Randomized trial examines lung abnormalities predicting heart issues in cardiac sarcoidosis patients, indicating no strong connection.

Key Points

  • To investigate the relationship between pulmonary parenchymal abnormalities and cardiac outcomes in patients with cardiac sarcoidosis.
  • Included 42 patients with cardiac sarcoidosis diagnosed by specialists.
  • Analyzed chest CT scans and pulmonary function tests within 3 months of diagnosis.
  • Utilized ANOVA and t-tests to assess the relationship between CT patterns, lung function, and adverse cardiac events.
  • No significant differences in cardiac outcomes between patients with normal, nonfibrotic, and fibrotic lung abnormalities.
  • Patients who developed atrial fibrillation had lower ppFEV1 and ppFVC compared to those without it (p=0.027 and p=0.031 respectively).
  • Overall, pulmonary function showed no significant associations with other adverse cardiac outcomes.

Cite This Study

Lemma et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5122f03e14405aa9d83ehttps://doi.org/10.1093/ajrccm/aamag162.2532
View Full Paper
Ask AI
Bookmark
Share